Goyal Associates Limited Appoints Satya Narayana Gogula as Additional Independent Director
Goyal Associates Limited appointed Satya Narayana Gogula as Additional Independent Director for five years from February 20, 2026, following board approval on the same date. The company later clarified that the board meeting was held from 02:30 p.m. to 03:30 p.m. after inadvertently omitting these details in the original announcement. Mr. Gogula brings over six years of experience in corporate operations, taxation, and business management from organizations including Amazon and Ryanwell India Pharma Pvt. Ltd. The appointment is subject to member approval in the ensuing general meeting and complies with all SEBI regulatory requirements.

*this image is generated using AI for illustrative purposes only.
Goyal Associates Limited has appointed Mr. Satya Narayana Gogula as Additional Independent Director, effective February 20, 2026. The appointment was approved during a board meeting held on the same date and requires member approval in the upcoming general meeting.
Board Meeting Details
The company submitted a clarification to BSE Limited on April 8, 2026, addressing an inadvertent omission in its original corporate announcement. The clarification provided the missing board meeting timings that were required under regulatory compliance.
| Meeting Details: | Information |
|---|---|
| Date: | February 20, 2026 |
| Commencement Time: | 02:30 p.m. |
| Conclusion Time: | 03:30 p.m. |
Director Appointment Details
Mr. Gogula's appointment as Additional Non-Executive Independent Director comes with a five-year term starting from February 20, 2026. The company confirmed that he has not been debarred from holding directorial positions by SEBI or any other authority, in compliance with regulatory requirements.
| Appointment Parameters: | Details |
|---|---|
| Director Name: | Satya Narayana Gogula |
| DIN: | 10209811 |
| Position: | Additional Independent Director |
| Term Duration: | 5 consecutive years |
| Effective Date: | February 20, 2026 |
| Relationship to Existing Directors: | Not related to any current director |
Professional Background
Mr. Gogula brings significant professional experience to the board. He is described as a dynamic professional with diversified experience across corporate operations, taxation, and business management. His career spans over six years in the industry, including positions with notable organizations such as Amazon and Ryanwell India Pharma Pvt. Ltd.
The company highlighted that his experience in business operations and marketing-driven growth environments will strengthen Goyal Associates Limited's strategic focus on:
- Business development initiatives
- Market expansion strategies
- Organizational growth programs
Regulatory Compliance
The appointment was made pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015. The company provided all required disclosures under Regulation 30 of the SEBI (LODR) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/CIR/2023/123 dated July 13, 2023.
The clarification filing demonstrates the company's commitment to maintaining compliance with applicable provisions of SEBI (LODR) Regulations and relevant circulars. The document was digitally signed by Vuppala Naga Malleswara Rao, Chairman and Director of Goyal Associates Limited.
Historical Stock Returns for Goyal Associates
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.37% | +8.24% | +12.20% | -11.54% | -36.99% | -78.85% |
What specific strategic initiatives might Goyal Associates pursue given Mr. Gogula's Amazon and pharma industry experience?
How will the addition of an independent director with marketing expertise impact the company's market expansion plans?
What challenges might arise during the member approval process for this directorial appointment at the upcoming general meeting?




























